Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Supernus’ sNDAs receive final FDA approval for Trokendi XR for migraine prophylaxis

pharmaceutical-technologyApril 10, 2017

Tag: Pharmaceuticals , FDA

PharmaSources Customer Service